An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis - NCT00751881-05201 (Clinical Trial 382083)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy382083.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Bennington |
|
State:
|
|
VT |
| Zip Code: |
|
05201 |
| Conditions: |
|
Multiple Sclerosis |
| Purpose: |
|
The objective of the study is to evaluate the effect of two doses of teriflunomide on the
frequency of relapses in patients with relapsing multiple sclerosis. The effect on
worsening of disability, fatigue and safety will also be evaluated.
|
| Study summary: |
|
The minimum duration on treatment for any patient not withdrawing prematurely is 48 weeks.
For those patients who complete the treatment period, a long term extension study will be
proposed. |
| Criteria: |
|
Inclusion Criteria:
- Relapsing multiple sclerosis
- Two relapses in prior 2 years or one relapse in prior year
Exclusion Criteria:
- Patients with clinically relevant cardiovascular, hepatic, neurological, endocrine or
other major systemic disease
- Patients with significantly impaired bone marrow function
- Pregnant or nursing women
- Alcohol or drug abuse
- Use of cladribine, mitoxantrone, or other immunosuppressant agents such as
azathioprine, cyclophosphamide, cyclosporin, methotrexate or mycophenolate before
enrollment
- Human immunodeficiency virus (HIV) positive patients
- Any known condition or circumstance that would prevent in the investigator's opinion
compliance or completion of the study
The above information is not intended to contain all considerations relevant to a
patient's potential participation in a clinical trial. |
|
|
|
| Study is available at: |
|
Sanofi-Aventis Investigational Site Number 840006
Bennington, VT 05201
United States
Primary Contact:
For site information, send an email with site number to
Email: GV-contact-us@sanofi-aventis.com |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|